26 min listen
Solving the Rare Disease Equation - Dr. Alaa Hamed, Global Head of Medical Affairs, Rare Diseases at Sanofi
FromRaise the Line
Solving the Rare Disease Equation - Dr. Alaa Hamed, Global Head of Medical Affairs, Rare Diseases at Sanofi
FromRaise the Line
ratings:
Length:
24 minutes
Released:
Nov 30, 2022
Format:
Podcast episode
Description
As we continue our focus on rare diseases on Raise the Line, we’re delighted to be joined by Dr. Alaa Hamed, Global Head of Medical Affairs, Rare Diseases at Sanofi, one of the leading pharmaceutical companies in the world. Although most well known for their focus on lysosomal storage disorders including Gaucher and Pompe disease, Dr. Hamed and his team at Sanofi are also working in adjacent disease spaces depending on the systems affected. “For example, the lysosome in Pompe disease affects the neuromuscular tissues, so we have a neuromuscular disorder interest as well.” In their discussion, Dr. Hamed and host Shiv Gaglani also touch on the efforts Sanofi is making to shorten the diagnostic odyssey for rare disease patients, including building more disease awareness and greater global infrastructure. “From the inception, we thought that having universal access is a key part of the rare disease equation.” You’ll also learn about the challenges of drug development, the importance of maintaining policy incentives to focus on rare diseases, and where innovation is needed most to advance outcomes for patients. Mentioned in this episode: https://www.sanofi.com/
Released:
Nov 30, 2022
Format:
Podcast episode
Titles in the series (100)
Prisma Health Physicians Create Ventilator Device That Could Save Lives: After seeing Italy confront the grim reality of ventilator rationing, emergency medicine specialist Dr. Sarah Farris wanted to spare physicians and patients in the U.S. the same agonizing choices. Creating a splitting device that would allow one ventilator to serve two patients seemed like a good solution, and in a remarkable sequence of events, thousands of those devices were manufactured and ready for use just a few weeks after she first mentioned the idea. Sarah and her colleagues at Prisma Health, Dr. Marjorie Jenkins and Dr. Peter Tilkemeier, join host Rishi Desai to describe the powerful partnership of medicine, government and industry that made it possible. by Raise the Line